Breaking News

Geron Corp. Grants License to P&G

November 22, 2005

Biopharmaceutical company Geron Corp. has granted a non-exclusive license to Procter & Gamble relating to Geron’s human telomerase reverse transcriptase (hTERT) technology for cell research applications. Financial terms of the agreement were not disclosed.
P&G plans to use the technology to create immortalized cell lines from certain types of skin cells to study the regulation of cell function and to develop biological tests for screening purposes.
Cell lines immortalized with hTERT technology can proliferate indefinitely while maintaining normal physical and biological characteristics, according to experts. Executives said this means P&G will be able to conduct repeated or long-term studies on the biology and functin of the cells.
blog comments powered by Disqus
  • Senior Skin Care

    Senior Skin Care

    Christine Esposito, Associate Editor||July 19, 2016
    McCord Research and Product Quest Manufacturing roll out new hospital-grade skin care kits for seniors to use at home.

  • Naterra Expands Tree Hut Range

    Naterra Expands Tree Hut Range

    Melissa Meisel, Associate Editor||July 18, 2016
    New ‘Bare’ collection is out now.

  • An Antioxidant Arsenal

    An Antioxidant Arsenal

    July 11, 2016
    BioRewind is Dermarché Labs' new anti-aging regimen that delivers broad-spectrum antioxidant protection against free radicals

  • Sustainability is Omnipresent

    Sustainability is Omnipresent

    Christine Esposito , Associate Editor||July 1, 2016
    Industry stakeholders convene in New York City for Organic Monitor’s annual event

  • Perceived Perfection

    Perceived Perfection

    Christine Esposito, Associate Editor||July 1, 2016
    From primers to pressed powders, facial cosmetics help create the illusion of a flawless complexion.

  • Preserve & Serve

    Preserve & Serve

    Melissa Meisel , Associate Editor||July 1, 2016
    Suppliers with innovative preservatives provide staying power for formulations.